A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with numerous of members share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Medical Experts Express Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, legal action or prison.
Platform Reaction and Material Removal
Based on TikTok, the service has taken down problematic content and banned related keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one group, a seller shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, posts show dark colored packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service stated it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.
Her staff has already encountered patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.
